In the blocking step, hydrophobic moieties causing “stickiness” in the specimen surface are rendered hydrophilic to minimize background. Nevertheless, the more dynamic charge-based  

interaction between the specimen surface and immunoreagents also needs to be controlled in order to eliminate background.

Aurion has developed BSA-c™, a unique incubation buffer additive with an unparalleled ability to effectively prevent charge based background. BSA-c™ is prepared by acetylation of 

bovine serum albumin (BSA). Polycationic sites in the specimen interact readily with negatively charged acetylated BSA molecules. This significantly reduces the risk that such sites might 

bind negatively-charged immunoreagents and immunogold conjugates and thus reduces the risk of background.


Procedures to eliminate background comprise three main steps:

1. To suppress residual aldehyde activity

2. To saturate multipoint hydrophobic moieties and positive charges with high molecular weight compounds such as those present in the AURION Blocking Solutions

3. To reduce non-specific binding of immunoreagents caused by hydrophilic interaction with competing molecules in the incubation and washing solution.

AURION BSA-c™ is a particularly effective reagent for this purpose.

AURION BSA-c™ is a buffer additive that helps prevent immunodetection reagents (i.e. primary antibodies and secondary reagents) from binding nonspecifically to charged moieties within 

the specimen. Thus, it suppresses background competitively with little or no effect on the specific reaction. Its successful application is not limited to immunogold detections but it is equally 

efficient in fluorescent and enzyme-based detection systems. AURION BSA-c™ concentrations as low as 0.01-0.1% inhibit binding of  gold conjugate to polycationic poly-l-lysine coated 

grids almost completely (>99%).

The surface properties of the specimen can be simplified by division into four compartments:

– negatively charged (polyanions, proteins, especially after aldehyde fixation, lipids);

0  neutral;

+ positively charged (histone proteins, polycations) and

H hydrophobic (lipids, fat droplets, resins). After an appropriate blocking step these areas are covered with blocking compounds.

In low ionic strength media negatively charged antibodies and gold conjugates are repulsed by negatively charged specimen areas which frequently may contain the antigens to be detected. 

Background does not likely occur in such areas. The positively charged areas attract antibodies and gold conjugates potentially leading to background. In a moderate ionic strength incubation 

solution, repulsion and attraction are diminished due to the presence of ions. The negatively charged BSA-c™ competes with the negatively charged antibodies and gold reagents for non-

specific binding to the positively charged specimen compounds, thus reducing background to the greatest possible extent without interfering with antigen detection.

Product Description

AURION BSA-c™ concentrated solution contains acetylated bovine serum albumin as the functional constituent. By acetylation of amines on basic amino acids these groups are no longer 

as easily protonated and the isoelectric point of such molecules is lowered and hydrophobicity is increased. BSA-c™ is a 10% solution of acetylated BSA at slightly alkaline pH with Kathon 

CG as preservative. The bovine serum albumin that Aurion uses to prepare BSA-c™ is obtained from healthy livestock.

The charge dependent background inhibition capacity of the BSA-c™ in each lot is determined using a dot-spot test system with polycationic compounds.

Two package volumes are available which yield 1.5 – 3 and 5 -10 litres of incubation buffer respectively

Application Instructions

Detailed information is provided in the package inserts.

Recommended Incubation Solution:


(10 mM Phosphate buffer, 150 mM NaCl)

0.1-0.2 % AURION BSA-c™

15 mM NaN3

pH 7.4

After addition of the BSA-c™ concentrate the pH should be checked and adjusted to 7.4 if necessary.

This Incubation Solution is used throughout the whole set of reactions and washing steps (i.e. from immediately after the blocking step, through the primary antibody incubations, in-between 

washing steps, secondary incubation and the final washing steps).


AURION BSA-c™ concentrate has a guaranteed shelf life of 18 months from the date of quality control analysis. The products should be stored at 4-8°C. Freezing is not recommended.

Ordering informations

 Catalog No. 

  Product Name



AURION BSA-c / concentrate (10%) 

100 ml 


30 ml 

▣ 관련 페이지 ;  Aurion 


등록된 댓글이 없습니다.

Copyright by Sambo Medical Co. All rights reserved.